Skip to content
10-Q

Quarterly Report

Theriva Biologics, Inc. TOVX

0001104659-25-109828

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 33.74M sh
Shares Diluted Q3 2025 · Sep 30, 2025 9.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 6.43M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.13M sh
Shares Diluted Q3 2025 · Sep 30, 2024 866.53K sh
Capex Q3 2025 · Sep 30, 2025 $35K
Capex Q3 2025 · Sep 30, 2024 $1K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$13.79M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$12.25M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $7.53M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $11.61M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $16.41M
Current Liabilities Q3 2025 · Sep 30, 2025 $11M
Current Liabilities Q3 2025 · Dec 31, 2024 $7.59M
Total Liabilities Q3 2025 · Sep 30, 2025 $24.1M
Total Liabilities Q3 2025 · Dec 31, 2024 $16.29M
Current Assets Q3 2025 · Sep 30, 2025 $9.9M
Current Assets Q3 2025 · Dec 31, 2024 $16.28M
Total Assets Q3 2025 · Sep 30, 2025 $30.84M
Total Assets Q3 2025 · Dec 31, 2024 $35.35M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.45
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$6.81
Eps Diluted Q3 2025 · Sep 30, 2024 −$24.47
Eps Basic Q3 2025 · Sep 30, 2025 −$0.45
Eps Basic Q3 2025 · Sep 30, 2025 −$3.38
Eps Basic Q3 2025 · Sep 30, 2024 −$6.81
Eps Basic Q3 2025 · Sep 30, 2024 −$24.47
Sga Expense Q3 2025 · Sep 30, 2025 $1.89M
Sga Expense Q3 2025 · Sep 30, 2025 $14.52M
Sga Expense Q3 2025 · Sep 30, 2024 $2.3M
Sga Expense Q3 2025 · Sep 30, 2024 $5.7M
Rd Expense Q3 2025 · Sep 30, 2025 $2.55M
Rd Expense Q3 2025 · Sep 30, 2025 $7.47M
Rd Expense Q3 2025 · Sep 30, 2024 $2.73M
Rd Expense Q3 2025 · Sep 30, 2024 $9.15M
Operating Income Q3 2025 · Sep 30, 2025 −$4.44M
Operating Income Q3 2025 · Sep 30, 2025 −$21.99M
Operating Income Q3 2025 · Sep 30, 2024 −$7.89M
Operating Income Q3 2025 · Sep 30, 2024 −$21.77M